Security
ALEXZA PHARMACEUTICALS INC Common Stock · ALXA
ALXAOTCCommon stockHistorical · closed Jun 21, 2016CIK 1344413Updated Nov 16, 2026
ALXA price & chart
Historical security
This listing closed Jun 21, 2016. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2015 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 14,731,000Source | 61,560,000Source | 47,072,000Source | 40,551,000Source |
| Property, Plant and Equipment, NetUSD | 3,320,000Source | 13,953,000Source | 14,991,000Source | 16,531,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 7,755,000Source | 15,200,000Source | 17,306,000Source | 17,715,000Source |
| Inventory, NetUSD | 0Source | 3,729,000Source | 3,447,000Source | — |
| Assets, CurrentUSD | 10,992,000Source | 41,785,000Source | 30,913,000Source | 23,618,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,237,000Source | 3,109,000Source | 1,453,000Source | 852,000Source |
| Other Assets, NoncurrentUSD | 419,000Source | 3,065,000Source | 1,168,000Source | 402,000Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | — | — | — |
| Common Stock, Value, IssuedUSD | 2,000Source | 2,000Source | 2,000Source | 2,000Source |
| Retained Earnings (Accumulated Deficit)USD | -432,270,000Source | -410,960,000Source | -374,228,000Source | -334,613,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 0Source | -3,000Source | 1,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | -71,658,000Source | -51,653,000Source | -23,975,000Source | 2,573,000Source |
| Additional Paid in Capital, Common StockUSD | 360,610,000Source | 359,308,000Source | 350,250,000Source | 337,184,000Source |
| Liabilities and EquityUSD | 14,731,000Source | 61,560,000Source | 47,072,000Source | 40,551,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 58,198,000Source | 11,517,000Source | 14,898,000Source | 18,718,000Source |
| Accounts Payable, CurrentUSD | 442,000Source | 1,799,000Source | 3,789,000Source | 2,147,000Source |
| Other Liabilities, NoncurrentUSD | 1,752,000Source | 985,000Source | — | — |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | — | 22,800,000Source |
| Deferred Revenue, CurrentUSD | 2,848,000Source | 2,450,000Source | 2,915,000Source | 2,915,000Source |
| Deferred Revenue, NoncurrentUSD | 0Source | 3,063,000Source | 2,185,000Source | 5,101,000Source |
| Long-term DebtUSD | 28,000,000Source | 25,000,000Source | 15,781,000Source | — |
| Restricted Cash and Investments, CurrentUSD | — | — | — | 5,051,000Source |
cash flow · annual statements
| Line item | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 3,001,000Source | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,120,000Source | 427,000Source | 3,371,000Source | 5,001,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | -2,500,000Source | 282,000Source | 3,447,000Source | — |
| Increase (Decrease) in Accounts PayableUSD | -1,357,000Source | -1,990,000Source | 1,642,000Source | -1,456,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | -612,000Source | -18,241,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | -10,345,000Source | 1,973,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 58,000Source | 2,363,000Source | 1,784,000Source | 452,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | 10,548,000Source | 19,081,000Source |
| Repayments of Long-term DebtUSD | — | — | 5,773,000Source | 6,110,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance Costs and DiscountsUSD | 2,246,000Source | 2,216,000Source | 1,079,000Source | 447,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | — | 22,800,000Source |
| DepreciationUSD | — | 3,393,000Source | 3,323,000Source | 4,336,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | -8,000Source | 15,000Source | — |
| General and Administrative ExpenseUSD | 12,205,000Source | 13,344,000Source | 15,778,000Source | 11,093,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Inventory Write-downUSD | 1,229,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -21,310,000Source | -36,732,000Source | -39,615,000Source | -27,978,000Source |
| Proceeds from Issuance of Common StockUSD | 182,000Source | 5,878,000Source | 6,583,000Source | 35,242,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 2,914,000Source | 50,830,000Source | 15,000,000Source | — |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 25,292,000Source | 30,840,000Source | 10,650,000Source | 2,000,000Source |
| Restricted Cash and Investments, CurrentUSD | — | — | — | 5,051,000Source |
income statement · annual statements
| Line item | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|
| Total RevenueUSD | 2,671,000Source | 2,997,000Source | 47,839,000Source | 4,070,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Operating Income (Loss)USD | -40,024,000Source | -37,456,000Source | 1,770,000Source | -28,872,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -21,310,000Source | -36,732,000Source | -39,615,000Source | -27,978,000Source |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 45,050,000Source | 43,017,000Source | 46,069,000Source | 32,942,000Source |
| General and Administrative ExpenseUSD | 12,205,000Source | 13,344,000Source | 15,778,000Source | 11,093,000Source |
| Interest ExpenseUSD | 8,446,000Source | 7,438,000Source | 1,498,000Source | 1,426,000Source |
| Research and Development ExpenseUSD | 11,716,000Source | 13,748,000Source | — | — |
| Sales Revenue, Goods, Net (Deprecated 2018-01-31)USD | 2,355,000Source | 2,564,000Source | — | — |